43 results about "Disc degeneration" patented technology

The Annulus Fibrosus Stent (AFS) is a platform of barriers used in the intervertebral disc. The barrier can be inserted into an intervertebral disc to act to reinforce and / or supplement the disc. The AFS can be inserted at any of the many different stages of disc pathology. The AFS can be inserted to prevent pressure and dissection of disc material which in and of itself can decrease and / or eliminate pain from damaged AF fibers. The AFS can be inserted before disc pathology progresses to a substantial event such as a disc herniation. It can be inserted at any time in the progression of the natural history of disc disease. It can even be inserted when substantially the entire intervertebral disc has been removed. It can be inserted in conjunction with another procedure such as a Nucleus Pulposus Replacement (NPR) or Total Disc Replacement (TDR), etc. The various shapes and material of the AFS in this patent are designed to address particular clinical situations, particular anatomy and particular stages of disc degeneration. The AFS can be inserted directly through the AF, or by a technique of detaching part of the AF with bone without actually cutting a substantial part of AF fibers or layers of fibers or by the Transosseous approach.

Balloon cannula systems may be used for accessing and visualizing the spine and related methods of treatment, including a forward-looking balloon system for creating a working space and the balloon system having atraumatic dissection capability to allow visualization in spine. The devices and methods described may be used, for example, to perform annulus repair, herniated disc excision, and denervation of neurological tissue; to dispense pharmacological agents and / or cell or tissue therapy agents; to diagnose disc degeneration and bony degeneration, spinal stenosis, and nucleus decompression, and to perform disc augmentation.

The invention broadly facilitates reconstruction of the Annulus Fibrosus (AF) or the AF and the Nucleus Pulposus (NP). Such Reconstruction prevents recurrent herniation following Microlumbar Discectomy (MLD) other procedures. The invention may also be used in the treatment of herniated discs, annular tears of the disc, or disc degeneration, while enabling surgeons to preserve the contained NP. The methods and apparatus may be used to treat discs throughout the spine including the cervical, thoracic, and lumbar spines of humans and animals. In the preferred embodiment, a spinal repair system according to the invention comprises a first end portion adapted for placement within an intervertebral body, a second end portion adapted for placement within an adjacent intervertebral body, and a bridge portion connecting the first and second end portions, the bridge portion being adapted to span a portion of an intervertebral disc space and prevent excessive outward bulging.

The intervertebral disc is avascular. With aging, endplates become occluded by calcified layers, and diffusion of nutrients and oxygen into the disc diminishes. The disc degenerates, and pain ensues. Conduits are delivered and deployed into the intervertebral disc to re-establish the exchange of nutrients and waste between the disc and bodily circulation to stop or reverse disc degeneration and relieve pain. The intervertebral disc installed with semi-permeable conduits may be used as an immuno-isolated capsule to encapsulate donor cells capable of biosynthesizing therapeutic molecules. The semi-permeable conduits establish the exchange of nutrients and therapeutic molecules between disc and bodily circulation to treat a disease without using immuno-suppressive drugs.

A prosthetic nucleus prepared from blends of polyvinylalcohol and polyvinyl pyrollidone or its copolymers for replacement of the nucleus pulposus in intervertebral discs is provided. Also provided are methods of replacing the nucleus pulposus and treating disc degeneration-associated pain in mammals using this prosthetic nucleus.

Balloon cannula systems may be used for accessing and visualizing the spine and related methods of treatment, including a forward-looking balloon system for creating a working space and the balloon system having atraumatic dissection capability to allow visualization in spine. The devices and methods described may be used, for example, to perform annulus repair, herniated disc excision, and denervation of neurological tissue; to dispense pharmacological agents and / or cell or tissue therapy agents; to diagnose disc degeneration and bony degeneration, spinal stenosis, and nucleus decompression, and to perform disc augmentation.

A vertebral disc tensioning device that restores the loss of disc height as a result of disc degeneration and other factors. The device includes first and second pedicle screws each including a screw body portion and a ball head. The device also includes first and second screw head portions each including an internal threaded bore where the first screw is inserted in the first screw head portion and is pivotally mounted relative thereto and the second screw is inserted in the second screw head portion and is pivotally mounted thereto. The device also includes a rigid connector that couples the first and second screw head portions where bolts are threaded through the connector and into the internal threaded bores of the first and second screw head portions. The device also includes a spring assembly offset from the rigid connector that applies a bias to separate the pedicle screws.

The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.

Various devices and methods for accessing and preparing treatment sites within the intervertebral disc space for subsequent negligible-incision surgical (NIS) or percutaneous procedures to treat disc degeneration and disc related back pain are disclosed. Also disclosed is a method for performing a percutaneous spine procedure including preparing a treatment site within the intervertebral disc space for subsequent delivery of a biomaterial to treat disc degeneration and disc related back pain.

The intervertebral disc is avascular. With aging, endplates become occluded by calcified layers, and diffusion of nutrients and oxygen into the disc diminishes. The disc degenerates, and pain ensues. Conduits are delivered and deployed into the intervertebral disc to reestablish the exchange of nutrients and waste between the disc and bodily circulation to stop or reverse disc degeneration and relieve pain. The intervertebral disc installed with semi-permeable conduits may be used as an immuno-isolated capsule to encapsulate donor cells capable of biosynthesizing therapeutic molecules. The semi-permeable conduits establish the exchange of nutrients and therapeutic molecules between disc and bodily circulation to treat a disease without using immunosuppressive drugs.

A vertebral disc annular fibrosis tensioning and lengthening device that restores the loss of disc height as a result of disc degeneration and other factors. The vertebral disc annular fibrosis tensioning and lengthening device includes pedicle screws having heads with cup-shaped cavities. The pedicle screws are threaded into the vertebral bodies of adjacent vertebrae through the pedicles so that open parts of the heads of the pedicle screws face each other. A spring is inserted into the cup-shaped cavities in compression so that the spring bias forces the pedicle screws apart, thus increasing the height of the disc space.

Systems and methods for treating disc herniation or degeneration, disc degeneration, and vertebral body fracture include surgical and endoscopic access and removal of disc tissue. The tissue removal devices that may be used include rotatable blade devices having flow control surfaces that may be inserted into a vertebral disc and rotated to pulverize the disc material and facilitate its removal.

A prosthetic nucleus prepared from blends of polyvinylalcohol and polyvinyl pyrollidone or its copolymers for replacement of the nucleus pulposus in intervertebral discs is provided. Also provided are methods of replacing the nucleus pulposus and treating disc degeneration-associated pain in mammals using this prosthetic nucleus.

A method for delivering particles to a target location of a subject includes slidably disposing a polymeric carrier in a lumen of a catheter. The lumen extends in the catheter from a proximal opening to a delivery region. The method further includes inserting the delivery region of the catheter in the target location of the subject and forcing the particles through the lumen of the catheter to cause the carrier and the particles to exit the delivery region of the catheter. The particles may be cells or drug-loaded microspheres. The carrier can serve to retain the particles in the target location for a period of time. For treatment of vertebral disc degeneration, the particles can be stem cells, the carrier can be formed from collagen, and the target location can be the nucleus pulposus.

The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.

A method for delivering particles to a target location of a subject includes slidably disposing a polymeric carrier in a lumen of a catheter. The lumen extends in the catheter from a proximal opening to a delivery region. The method further includes inserting the delivery region of the catheter in the target location of the subject and forcing the particles through the lumen of the catheter to cause the carrier and the particles to exit the delivery region of the catheter. The particles may be cells or drug-loaded microspheres. The carrier can serve to retain the particles in the target location for a period of time. For treatment of vertebral disc degeneration, the particles can be stem cells, the carrier can be formed from collagen, and the target location can be the nucleus pulposus.

Systems, computer-readable media, and methods are described for assessing physiological condition of spinal intervertebral discs in a quantitative manner using magnetic resonance imaging (MRI) data A simple, objective, continuous measurement of disc health or degeneration / pathology is provided, using routinely acquired or other digital magnetic resonance imaging (MRI) sequences. The measurement includes calculation of a value based on one or more ratios from signal-based measurements of spinal disc structures or regions, which can be obtained either through manual tracing or automated through programming of image analysis software. The measurement can be implemented by a computer and / or stored on a computer readable storage medium.

A method for providing an InVivo model of disc degeneration. The method includes percutaneously inserting a needle into a non-human surrogate disc, generally the disc of a rabbit, so that the needle ruptures the annulus of the disc. Fluoroscopy X-ray images can be used to visualize the placement of the needle to the proper location. By using the proper surrogate, rupture of the annulus of the disc will have a quick degenerative effect on the disc, which can be visualized using MRI or other suitable imaging devices. By studying the etiologies associated with disc degeneration of the surrogate, treatments can then be devised to attempt to reduce the rate of degeneration, reverse degeneration, or other disc treatment procedures.

NMR spectroscopy is performed on intervertebral disc tissue. Extent of degeneration is determined based on the NMR spectroscopy. Correlation between NMR spectral regions and pain are made. Accordingly, NMR spectroscopy is used to determine location and / or extent of at least one of disc degeneration, or discogenic pain.

The invention is applicable to the technical field of medicines, and provides an application of tert-butyl hydroquinone and a drug for treating intervertebral disc degeneration. The drug for treatingintervertebral disc degeneration comprises a drug carrier and tert-butyl hydroquinone, wherein the tert-butyl hydroquinone is a safe and efficient edible oil antioxidant and has a good antioxidant effect. Compared with other drugs, the tert-butyl hydroquinone serving as a food additive component can relieve intervertebral disc degeneration more mildly. The tert-butyl hydroperoxide is applied to induce oxidative stress to construct an intervertebral disc degeneration model, the treatment effect of the tert-butyl hydroquinone on intervertebral disc degeneration is evaluated by observing variousindexes of oxidative stress, cell apoptosis and intervertebral disc degeneration, and a substitute treatment drug can be provided for comprehensive treatment of intervertebral disc degeneration diseases.